跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,148 条关于
“alpha 1B/2C receptors”
全部
13,148
临床试验
7,999
药物
1,749
机构
28
资讯
3,372
2年前
FDA Accepts Brexpiprazole-Sertraline Combination for PTSD Review, Marking First Potential New Treatment in Over 20 Years
去年
Atamyo Therapeutics' ATA-200 Gene Therapy Receives FDA Clearance for US Clinical Trial in LGMD2C/R5
去年
First Patient Dosed in Phase 1 Trial of ABS-0871 for Charcot-Marie-Tooth Disease 2C Treatment
去年
NMDA Receptor Research Reveals Novel Mechanism for Brain Stabilization and Potential Depression Treatments
去年
Alpha Tau Secures MDSAP Certification for Alpha DaRT Cancer Therapy Manufacturing Facility
2年前
Atamyo Therapeutics Advances Gene Therapy Programs for Limb-Girdle Muscular Dystrophy
去年
atai Life Sciences Secures $11.4 Million NIH Grant for Non-Hallucinogenic Opioid Use Disorder Treatment
去年
Actio Biosciences Raises $66M Series B to Advance Rare Disease Programs Targeting Ion Channel Disorders
去年
FDA Clears Atamyo's ATA-200 Gene Therapy Trial for LGMD2C/R5 in Children
去年
Duke University Develops SBI-810, Novel Non-Opioid Painkiller Targeting Specific Brain Receptors
第 1 页,共 338 页
上一页
下一页